logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
Showing 1 - 2 of 2 Items
Showing 1 - 2 of 2 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Review

Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings

Ford NP, Lee JS, Andrieux-Meyer I, Calmy A
2012-01-11 • HIV/AIDS - Research and Palliative Care
2012-01-11 • HIV/AIDS - Research and Palliative Care
Integrase inhibitors represent an important new class of antiretroviral drugs. Elvitegravir, the second available integrase inhibitor to be submitted for regulatory approval appears to b...
Journal Article
|
Review

Safety, efficacy, and pharmacokinetics of rilpivirine: systematic review with an emphasis on resource-limited settings

Ford NP, Lee JS, Andrieux-Meyer I, Calmy A
2011-04-28 • HIV/AIDS - Research and Palliative Care
2011-04-28 • HIV/AIDS - Research and Palliative Care
The vast majority of people living with human immunodeficiency virus (HIV)/acquired immune deficiency syndrome reside in the developing world, in settings characterized by limited health...